| NCT ID | NCT01889459 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kurashiki Central Hospital |
| Condition | Chronic Total Occlusion of Coronary Artery |
| Study Type | OBSERVATIONAL |
| Enrollment | 19,000 participants |
| Start Date | 2013-07 |
| Primary Completion | 2022-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 19,000 participants in total. It began in 2013-07 with a primary completion date of 2022-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to establish a consensus of treatment strategy of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) through patient registry of PCI for CTO performed by Japanese certified operators.
Eligibility Criteria
Inclusion Criteria: Patients eligible for PCI Patients who underwent PCI for CTO lesions that contain the following: 1. Thrombolysis in myocardial infarction trial (TIMI) 0 2. The occlusive period more than 3 months or unknown 3. The main coronary arteries (segment 1-3, 5-8, 11, 13), branches that have large perfusion area (segment 4PL, 9/10, 12) and graft Exclusion Criteria: Patients ineligible for PCI judged in clinical practice
Contact & Investigator
Frequently Asked Questions
Who can join the NCT01889459 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Chronic Total Occlusion of Coronary Artery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01889459 currently recruiting?
Yes, NCT01889459 is actively recruiting participants. Contact the research team at cto.e.registry@gmail.com for enrollment information.
Where is the NCT01889459 trial being conducted?
This trial is being conducted at Kurashiki, Japan.
Who is sponsoring the NCT01889459 clinical trial?
NCT01889459 is sponsored by Kurashiki Central Hospital. The trial plans to enroll 19,000 participants.